RxDoctor Payments Data

Henry Harrell, MD

Internal Medicine · Nashville, TNNPI 1104817907

Payments from drug & device makers

$1,079in general payments, 2019–2025

Across 57 payments — averaging $18.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$290
  • Astellas Pharma US Inc$202
  • Lilly USA, LLC$170
  • Pfizer$80
  • Phathom Pharmaceuticals, Inc.$80
  • GSK$62
  • plus $195 from 8 others

What the payments were for

  • Food & beverage$1,079100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,079 in reported general payments places this provider in the 70th percentile of 2,216 internal medicine providers in Tennessee.

See all internal medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$164,647
Medicare patients
329
Services billed
6,029

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban116$102,572
OzempicSemaglutide53$65,131
Tresiba Flextouch U-100Insulin Degludec56$30,845
FarxigaDapagliflozin Propanediol31$28,297
XareltoRivaroxaban28$24,613
JardianceEmpagliflozin20$20,800
CreonLipase/Protease/Amylase14$18,248
TrulicityDulaglutide14$16,339
MounjaroTirzepatide12$11,463
Breo ElliptaFluticasone/Vilanterol16$6,151
Valsartan109$5,567
Atorvastatin Calcium439$5,052
Sucralfate16$4,848
Metoprolol Succinate267$4,685
Omeprazole291$3,863

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$80$105,414150 claims
Novo NordiskOzempic$290$65,13153 claims
AstraZenecaFarxiga$60$28,29731 claims
Lilly USA, LLCTrulicity, Mounjaro$170$27,80126 claims
AbbVieCreon, Synthroid$14$21,97559 claims
Boehringer IngelheimJardiance$31$20,80020 claims
GSKBreo Ellipta$62$6,15116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,216 internal medicine providers in Tennessee.

Other internal medicine in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →